BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmedah HT, Patterson LH, Shnyder SD, Sheldrake HM. RGD-Binding Integrins in Head and Neck Cancers. Cancers (Basel) 2017;9:E56. [PMID: 28587135 DOI: 10.3390/cancers9060056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu H, Wang Z, He J, Li Z, Gao JY, Liu R, Lin P, Yang J. Promotion of Bone Lesions Through the Myeloma Integrin α6-Mediated Osteolytic Signaling. Front Oncol 2021;11:692190. [PMID: 34150666 DOI: 10.3389/fonc.2021.692190] [Reference Citation Analysis]
2 Tahmasebi E, Alikhani M, Yazdanian A, Yazdanian M, Tebyanian H, Seifalian A. The current markers of cancer stem cell in oral cancers. Life Sci 2020;249:117483. [PMID: 32135187 DOI: 10.1016/j.lfs.2020.117483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Arun AS, Tepper CG, Lam KS. Identification of integrin drug targets for 17 solid tumor types. Oncotarget 2018;9:30146-62. [PMID: 30046394 DOI: 10.18632/oncotarget.25731] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
4 Hale SJM, Perrins RD, Garcı A CE, Pace A, Peral U, Patel KR, Robinson A, Williams P, Ding Y, Saito G, Rodriguez MÁ, Perera I, Barrientos A, Conlon K, Damment S, Porter J, Coulter T. DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma. Bioconjug Chem 2019;30:703-13. [PMID: 30582799 DOI: 10.1021/acs.bioconjchem.8b00873] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Nardelli F, Ghitti M, Quilici G, Gori A, Luo Q, Berardi A, Sacchi A, Monieri M, Bergamaschi G, Bermel W, Chen F, Corti A, Curnis F, Musco G. A stapled chromogranin A-derived peptide is a potent dual ligand for integrins αvβ6 and αvβ8. Chem Commun (Camb) 2019;55:14777-80. [PMID: 31755501 DOI: 10.1039/c9cc08518a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Cui J, Yue JB. Current status and advances in arginine‐glycine‐aspartic acid peptide‐based molecular imaging to evaluate the effects of anti‐angiogenic therapies. Prec Radiat Oncol 2019;3:29-34. [DOI: 10.1002/pro6.60] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Nieberler M, Reuning U, Reichart F, Notni J, Wester HJ, Schwaiger M, Weinmüller M, Räder A, Steiger K, Kessler H. Exploring the Role of RGD-Recognizing Integrins in Cancer. Cancers (Basel) 2017;9:E116. [PMID: 28869579 DOI: 10.3390/cancers9090116] [Cited by in Crossref: 186] [Cited by in F6Publishing: 156] [Article Influence: 37.2] [Reference Citation Analysis]
8 Cedra S, Wiegand S, Kolb M, Dietz A, Wichmann G. Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients. Cancers (Basel) 2017;9:E117. [PMID: 28872582 DOI: 10.3390/cancers9090117] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
9 Wahbi W, Naakka E, Tuomainen K, Suleymanova I, Arpalahti A, Miinalainen I, Vaananen J, Grenman R, Monni O, Al-Samadi A, Salo T. The critical effects of matrices on cultured carcinoma cells: Human tumor-derived matrix promotes cell invasive properties. Exp Cell Res 2020;389:111885. [PMID: 32017929 DOI: 10.1016/j.yexcr.2020.111885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xu Q, Liu R, Wang J, Huang Y, Li S, Zhang L, Wang F. Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy. Nucl Med Biol 2020;88-89:34-43. [PMID: 32688289 DOI: 10.1016/j.nucmedbio.2020.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kamarajan P, Ateia I, Shin JM, Fenno JC, Le C, Zhan L, Chang A, Darveau R, Kapila YL. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin. PLoS Pathog 2020;16:e1008881. [PMID: 33002094 DOI: 10.1371/journal.ppat.1008881] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
12 Färber SF, Wurzer A, Reichart F, Beck R, Kessler H, Wester HJ, Notni J. Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6. ACS Omega 2018;3:2428-36. [PMID: 30023833 DOI: 10.1021/acsomega.8b00035] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]